Yearly Archives: "2016"

Ocrelizumab Shown Effective Against Relapsing, Progressive Forms of Multiple Sclerosis
The drug ocrelizumab was found effective in the treatment of multiple sclerosis in three different large-scale, multi-center trials [...]
21st Century Cures Act Expected to Bring Real Change to MS patients’ Lives
President Obama’s signing of the 21st Century Cures Act on Dec. 13 is expected to bring real change to those living with multiple [...]
Ari Waisman receives most prestigious European prize for multiple sclerosis research
The Sobek Foundation honors Professor Ari Waisman for his groundbreaking achievements in research into multiple sclerosis (MS). His [...]
Multiple Sclerosis – Better Ways to Test Diet Changes
Will a Mediterranean-style, non-dairy, low-carb diet improve symptoms for patients with multiple sclerosis (MS)? Helping MS patients by [...]
Imbalances in Brain Microbiota May be Behind Demyelination in MS, Study Says
Alterations in microorganisms in the brains of multiple sclerosis (MS) patients could contribute to underlying disease mechanisms, [...]
Consortium of Multiple Sclerosis Centers calls for abstracts for CMSC 2017 Annual Meeting
The Consortium of Multiple Sclerosis Centers (CMSC) is inviting researchers and healthcare professionals to submit abstracts to be [...]
Low Vitamin D Levels at Birth May Influence MS Risk in Adults, Study Suggests
The risk of developing multiple sclerosis (MS) later in life may be higher for babies born with low levels of vitamin D, according to a [...]
ICER Releases Draft Report on Disease-Modifying Therapies for MS, Welcomes Comment
The Institute for Clinical and Economic Review (ICER) has released a Draft Evidence Report evaluating the comparative clinical [...]
UV Light May Lead Way to New Treatment for MS and Inflammation
Researchers have found a way to harness inflammation with the help of ultraviolet (UV) light, making it possible to design an [...]
Acorda to Discontinue Dalfampridine for Treatment of Post-Stroke Walking Difficulties
ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the MILESTONE clinical study did not show [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM